AI translates doctor speak for cancer patients
NCT ID NCT07519811
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using artificial intelligence (AI) to rewrite medical discharge letters into plain language helps cancer patients better understand their diagnosis, treatment, and next steps. About 150 adults with blood cancer or other cancers will be randomly assigned to receive either the standard letter or both the standard and an AI-simplified version. After reading, they fill out a questionnaire to measure how well they understood the information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Technical University Munich
RECRUITINGMunich, Bavaria, 81675, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood cancer patients may need higher antibiotic doses to beat superbugs
- New antibody may offer safer shield against transplant complications
- Could virtual reality help patients recover faster from cell therapy?
- Could a 30-Day habit shift help blood cancer patients regain control?
- Can exercise help cancer patients? new study aims to find out
- Experimental blood cancer drug KK2430 enters first human tests